Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivasnephrology-urology-fluids-and-electrolytes

Paeds Vivas · nephrology-urology-fluids-and-electrolytes

Lupus nephritis and systemic disease: Viva

Branching clinical structured oral on paediatric lupus nephritis: the ISN/RPS six-class classification, the pathophysiology behind full-house immunofluorescence and low complement, the induction-maintenance treatment paradigm, and the approach to refractory disease and reproductive counselling in adolescence.

branching clinical structured oral3 min readVerification in progress

Target exams

RACP DWERACP DCEMRCPCH Clinical
On this page
Study tools

Target exams

RACP DWERACP DCEMRCPCH Clinical
Prompt
A 14-year-old girl is referred for investigation of facial swelling and dark urine. She has had fatigue and joint pains for two months. On examination she has a malar rash, oral ulcers, wrist synovitis, and blood pressure 140 over 90. Her urinalysis shows blood and protein, her complement C3 and C4 are low, and her anti-dsDNA is strongly positive. A renal biopsy shows proliferative changes in 65 percent of glomeruli with wire-loop deposits, crescents, and full-house immunofluorescence. The examiner asks how you would classify this disease, explain the mechanism, and design the treatment plan.

Branch 1: Classification and the biopsy

The candidate should identify this biopsy as Class IV diffuse proliferative lupus nephritis, the most common and most severe paediatric pattern. The defining feature is proliferative endocapillary and extracapillary change affecting 50 percent or more of glomeruli (65 percent in this case), with subendothelial deposits visible as wire-loop lesions and cellular crescents. A strong candidate should place this in the six-class ISN/RPS 2003 framework: Class I minimal mesangial and Class II mesangial proliferative are mild mesangial-only disease, Class III focal proliferative involves under 50 percent, Class IV diffuse proliferative involves 50 percent or more and is subdivided into IV-S segmental and IV-G global, Class V membranous shows subepithelial deposits with nephrotic-range proteinuria, and Class VI advanced sclerosing shows over 90 percent global sclerosis. The practical divide is proliferative (III, IV) versus non-proliferative. [1]

If the examiner presses on the full-house immunofluorescence, the candidate should explain that it means granular staining for all major immunoglobulins (IgG, IgA, IgM) and complement components (C3, C1q), which distinguishes lupus from other glomerulonephritides where the deposition is more restricted (IgA-dominant in IgA nephropathy). The candidate should also explain the activity-versus-chronicity indices: the activity index scores reversible inflammation (crescents, necrosis) and predicts response to immunosuppression, while the chronicity index scores irreversible damage (sclerosis, atrophy, fibrosis) and predicts the long-term outcome. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Weening JJ, D'Agati VD, Schwartz MM, et al The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol, 2004.PMID 14747370
  2. [2]Appel GB, Contreras G, Dooley MA, et al Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol, 2009.PMID 19369404
  3. [3]Fanouriakis A, Kostopoulou M, Cheema K, et al 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis, 2020.PMID 32220834
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousKidney transplantation in children: Vivanephrology-urology-fluids-and-electrolytesNextNephrolithiasis and nephrocalcinosis — vivanephrology-urology-fluids-and-electrolytes